Radoslaw Laufer,Grace Ng,Richard Brokx,Heinz W. Pauls,Sze-Wan Li,Jacqueline M. Mason,Mark R. Bray
申请号：
US16258753
公开号：
US20190225617A1
申请日:
2019.01.28
申请国别(地区):
US
年份:
2019
代理人:
摘要：
The invention is a compound represented by Structural Formula (I):or a pharmaceutically acceptable salt thereof. Values for the variables are provided herein. Also included is a pharmaceutical composition comprising the compound represented by Structural Formula (I) and a pharmaceutically acceptable carrier or diluent and methods of treating a subject with cancer with the compound of Structural Formula (I).
